- Robert F Kennedy Jr. has just announced that federal funding for research on mRNA vaccines has been cut by $500 million.
What about that “greatest medical breakthrough”?
Since the 1980s and prior to COVID-19, pharmaceutical companies had been dabbling in mRNA technology.
During this time, mRNA technology was largely a technique in search of a use...
Results generally fell short of the promise, plagued by ongoing concerns over stability and effectiveness...
As vaccines, however, mRNA technology has proved a mixed bag.
As vaccines, however, mRNA technology has proved a mixed bag.
- Reported adverse events (AE) are higher for the mRNA vaccines than for more traditional vaccines, although their incidence has arguably been exaggerated.
- Doubts have also swirled ever since about the effectiveness of the mRNA vaccines, and whether they prevent the disease or provide true immunity...
There is a deeper question to ask.
- Private industry funded much of the R&D behind mRNA vaccines.
- If it is such a promising technology, why can’t private industry step in and fund this work?...
No comments:
Post a Comment